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Beige adipocytes in white adipose tissues (WAT) are similar to classical brown adipocytes 
in that they can burn lipid storage to produce heat. Thus, an increase in beige adipocyte 
content (browning) in WAT would raise energy expenditure and reduce adiposity. Here we 
report that adipose-specific inactivation of Notch1 or its signaling mediator Rbpj in mice 
results in browning of WAT and elevated expression of UCP1, a key regulator of 
thermogenesis. Consequently, Notch mutants exhibit elevated energy expenditure, better 
glucose tolerance, improved insulin sensitivity, and are more resistant to high fat diet 
(HFD)-induced obesity. By contrast, adipose-specific activation of Notch1 leads to opposite 
phenotypes. At the molecular level, constitutive activation of Notch signaling inhibits, 
whereas Notch inhibition induces, Ppargc1a and Prdm16 transcription in white adipocytes. 
Notably, pharmacological inhibition of Notch signaling in obese mice ameliorates obesity, 
reduces blood glucose and increases UCP1 expression in white fat. Therefore, Notch 
signaling may be therapeutically targeted to treat obesity and Type 2 diabetes (T2D).
Global epidemics of obesity and its associated risks of chronic diseases including T2D pose 
formidable challenges to human health. Classical brown adipose tissues (BAT) prominently 
found in rodents and hibernating mammals dissipate extra energy to generate heat through 
uncoupled respiration mediated by UCP1, and thus increase energy expenditure and 
counteract obesity1-4. Metabolically active UCP1+ brown adipocytes have recently been 
detected in adult humans with advanced imaging techniques5-9. Interestingly, human 
adipose depots are highly heterogeneous and the brown adipocytes coexist with white and 
beige (brite) adipocytes10-12. Beige adipocytes are a class of adaptive thermogenic cells 
located within various depots of WAT13-17. Recent studies indicate that beige adipocyte 
homeostasis can be maintained through two mechanisms. First, they can be generated de 
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novo from a population of beige preadipocytes18,19. Second, they can be bidirectionally 
converted from and to white adipocytes under the control of environmental temperature or 
sympathetic nerve innervation20-22. Importantly, elevated UCP1 expression in cold 
acclimated beige adipocytes is associated with robust uncoupled respiration and 
thermogenesis23. Notably, appearance of beige or brown adipocytes in human is inversely 
correlated with obesity and T2D mellitus24,25, indicating their important role in regulating 
metabolism. Thus, identifying mechanisms underlying beige adipocyte biogenesis is 
instrumental to the development of therapeutics to reduce adiposity and risks of obesity-
related metabolic syndrome that affect over 10% of the world population.
Notch signaling is activated by binding of Dll or Jag family ligands with Notch receptors 
(Notch1–4), leading to γ-secretase mediated proteolytic cleavage and release of Notch 
intracellular domain (NICD)26. NICD then translocates to the nucleus where it binds with 
the Rbpj transcriptional complex to activate the transcription of downstream targets, 
including Hes and Hey family genes. Notch signaling has been shown to paradoxically 
either inhibit or facilitate the adipogenic differentiation of 3T3 L1 cells27-30. In murine and 
human primary cell cultures, Notch inhibition promotes, while Notch activation inhibits, 
adipogenic differentiation of mesenchymal and adipose-derived stem cells31-33. However, 
genetic ablation of several key components of the signaling pathway indicates that Notch 
signaling is dispensable for adipogenesis of mouse embryonic stem cells or embryonic 
fibroblasts derived from early embryos34. As these studies are conducted in cultured cells, 
the function of Notch signaling in adipose tissues in vivo remains unknown.
RESULTS
White to brown fat transition in adipose-specific Notch mutant mice
We first examined the relative expression of Notch pathway genes in different depots of 
WAT. Notably, the mRNA levels of Notch receptors and Notch targets were much higher in 
visceral epididymal (Epi) WAT than in subcutaneous inguinal (Ing) WAT (Supplementary 
Fig. 1a,b). By contrast, BAT-specific Ucp1, Ppargc1a and Prdm16 were expressed at lower 
levels in EpiWAT than in IngWAT (Supplementary Fig. 1c). An inverse correlation between 
activated Notch1 (N1ICD) and UCP1 at the protein level was also observed (Supplementary 
Fig. 1d). These results suggest that Notch signaling may play a role in regulating BAT-
specific gene expression in vivo.
To directly investigate how Notch signaling regulates adipose plasticity in vivo, we 
established an adipose-specific Notch1 knockout mouse model: aP2-Cre/Notch1flox/flox, 
henceforth named as aNotch1. To validate the tissue specificity of aP2-Cre, we evaluated 
YFP fluorescence in different organs of aP2-Cre/RosaEYFP reporter mice. As expected, 
adipocytes were all YFP+, but liver and muscle tissues, two important regulators of lipid and 
glucose homeostasis, were predominately YFP– with only few YFP+ interstitial cells 
(Supplementary Fig. 2a). Adipose macrophages, accounting for < 2% of total stromal 
vascular fraction (SVF) cells, were also predominantly YFP– (Supplementary Fig. 2b,c). 
PCR-based genotyping confirmed DNA recombination in adipose tissues of aNotch1 mice 
(Supplementary Fig. 2d). Accordingly, Notch1 expression was ~ 65% lower in adipose 
tissues and 85% lower in mature adipocytes, but unchanged in other tissues of the aNotch1 
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mice when compared to the wild-type (WT) mice (Supplementary Fig. 2e). Notably, various 
depots of subcutaneous WAT of aNotch1 mice appeared browner than their WT 
counterparts (Fig. 1a). In addition, the weight of various fat depots was lighter in the 
aNotch1 compared to WT mice (Fig. 1b). Furthermore, multilocular UCP1+ beige 
adipocytes were much more abundant in the IngWAT of aNotch1 versus in WT mice (Fig. 
1c). The average adipocyte sizes of aNotch1 WAT were ~ 40% smaller than those of WT 
(Fig. 1c). At the molecular level, expression of Ucp1, Cidea, Prdm16, Ppargc1a genes were 
upregulated in the IngWAT of aNotch1 mice compared with WT mice (Fig. 1d). Western 
blot confirmed the higher UCP1 protein levels in the aNotch1 IngWAT (Fig. 1e). In 
addition, mRNA levels of beige cell markers (Cd137, Tbx1), mitochondria genes (Cpt1a, 
Cpt2), and lipolysis enzymes (Atgl, Hsl) were all considerably higher in aNotch1 than in WT 
IngWAT (Fig. 1f). Similar browning phenotypes were observed in visceral EpiWAT, but not 
in BAT of the aNotch1 mutant mice (Supplementary Fig. 2f–h).
In parallel we generated another mouse model, aP2-Cre/Rbpjflox/flox (aRbpj). Genotyping 
and quantitative PCR (qPCR) confirmed the deletion of Rbpj DNA and the lower expression 
levels of Rbpj mRNA in aRbpj adipose tissues than in WT counterparts (Supplementary Fig. 
2d,i). Again, browner appearance of IngWAT was observed in aRbpj when compared with 
WT mice (Fig. 1g), associated with higher levels of BAT-specific genes (Fig. 1h). However, 
expression of these genes were not altered in the BAT (Supplementary Fig. 2i). Of note, the 
aNotch1 and aRbpj mice both had higher rectal temperatures than their WT siblings (Fig. 
1i,j), indicating that the higher UCP1 levels result in elevated thermogenesis in vivo.
Improved glucose metabolism in Notch mutant mice
In rodents and humans, brown adipocytes are shown to improve glucose metabolism and 
insulin sensitivity35,36. To check whether browning of WAT in aNotch1 mice elicits 
beneficial metabolic effects, we conducted intraperitoneal (IP) glucose- and insulin-
tolerance tests (GTT and ITT, respectively). Compared to their WT siblings, the aNotch1 
mice had lower blood glucose concentrations after glucose or insulin injection (Fig. 2a,b). 
We further measured insulin-stimulated glucose uptake by IngWAT explants, and found that 
aNotch1 IngWAT absorbed ~ 65% more glucose than their WT counterparts (Fig. 2c). 
Improved glucose tolerance and insulin-stimulated glucose clearance were also observed in 
the aRbpj mice (Fig. 2d,e). These in vivo and ex vivo experiments together suggest that the 
genetic disruption of Notch signaling in adipose tissue improves insulin sensitivity and 
blood glucose tolerance.
A physiological characteristic of beige cells is their highly active metabolism coupled to 
thermogenesis. We examined the metabolic rate of aNotch1 mice using indirect calorimetry 
approach. The aNotch1 mice had higher rates of oxygen (O2) consumption and carbon 
dioxide (CO2) production, and expended more energy than WT mice (Fig. 2f–h). To 
examine whether the metabolic changes are dependent on UCP1 function, mice were 
acclimated at thermoneutral condition (28.3 °C) for 3–5 weeks to block functional activation 
of UCP1. Notably, thermoneutrality abolished the beneficial metabolic phenotypes of the 
aNotch1 mice observed at room temperature, but not UCP1 protein expression 
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(Supplementary Fig. 3). This result suggests that browning of WAT in the aNotch1 mice 
leads to UCP1-dependent improvements of energy expenditure.
Contrary to thermoneutrality, cold stress induces formation of beige adipocytes and their 
adaptive thermogenesis through UCP1 upregulation and sympathetic nerve stimulation37. 
Notably, IngWAT of aNotch1 mice contained many more clusters of UCP1+ cells than the 
WT counterparts after exposed to 4 °C for 1 week (Fig. 2i). In addition, adipocytes in the 
aNotch1 IngWAT are predominantly multilocular and UCP1+, whereas WT IngWAT only 
contain a small fraction of such cells (Fig. 2i). These morphological changes were associated 
with elevated expression of UCP1 and PGC1-α in cold-acclimated aNotch1 compared to 
WT IngWAT (Fig. 2j). These results indicate that aNotch1 mice are more adaptive to cold-
induced thermogenesis.
The aNotch1 mice were resistant to HFD-induced obesity
In light of their better glucose tolerance, insulin sensitivity and higher metabolic rate, we 
predicted that the aNotch1 mice should be resistant to HFD-induced obesity. Indeed, the 
aNotch1 mice were leaner after fed with HFD for 4 weeks (Fig. 3a), even though their daily 
energy intake was similar to that of the WT littermates (Fig. 3b). In addition, the aNotch1 
mice retained better glucose tolerance and higher insulin sensitivity after HFD feeding (Fig. 
3c,d).
This observation prompted us to examine if HFD activates Notch signaling in WT mice. 
Upon HFD treatment, expression of Lep, a surrogate indicator of mature adipocytes and 
obesity, was increased by 20 folds (Fig. 3e), confirming the obesogenic effect of HFD. 
Coincidentally, mRNA and protein expression of Notch receptors and targets were induced 
by HFD (Fig. 3e,f). These results together suggest that activation of Notch signaling is 
associated with, and inactivation of Notch conversely prevents, HFD-induced obesity.
Adipocyte-specific activation of Notch signaling inhibits browning and glucose 
metabolism
As a complementary approach to the KO mouse models, we carried out gain-of-function 
studies using adiponectin (Adipoq)-Cre/RosaN1ICD mice (henceforth Adipoq/N1ICD). As 
expected, adipose tissue of Adipoq/N1ICD mice had higher expression levels of N1ICD, 
Hes1 and Hey1 (Fig. 4a). The Adipoq/N1ICD mice were slightly (~ 6%) heavier than their 
WT littermates even though they had similar food intake (Supplementary Fig. 4a,b). 
Notably, the Adipoq/N1ICD mice had lower glucose tolerance and insulin sensitivity 
compared with WT littermates (Fig. 4b,c). In addition, the metabolic rate and the body 
temperature of Adipoq/N1ICD mice were also lower (Fig. 4d–g), accompanied by lower 
expression levels of thermogenic and mitochondrial respiration-related genes in the 
IngWAT, but not in BAT (Fig. 4h,i). Furthermore, the Adipoq/N1ICD BAT accumulated 
more lipid droplets and the size of lipid droplets appeared larger than their WT counterparts 
(Fig. 4j). Compared to the WT mice, the Adipoq/N1ICD mice were also less responsive to 
cold-induced browning, manifested by lower abundance of UCP1+ beige adipocytes and 
lower expression levels of UCP1 and PGC1-α proteins in IngWAT after acclimated to 4 °C 
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(Supplementary Fig. 4c,d). Thus, genetic activation of Notch signaling in adipocytes impairs 
body energy metabolism.
Notch signaling inhibits the expression of Prdm16 and Ppargc1a in white adipocytes
To understand the cellular and molecular mechanisms through which Notch signaling 
regulates adipocytes, we first employed loss-of-function studies in cell culture. We cultured 
SVF preadipocytes from subcutaneous WAT of the Notch1flox/flox mice. Upon transfection 
with a Cre plasmid, the expression of Notch1 and its downstream target Hes1 were reduced 
by more than 50% (Fig. 5a), accompanied by an upregulation Prdm16 and Ppargc1a 
expression (Fig. 5a). In parallel, we inhibited Notch signaling in WT white adipocytes with a 
γ-secretase inhibitor, DAPT. DAPT upregulated the expression of Ucp1, Cidea, Prdm16, 
and Ppargc1a genes (Fig. 5b and supplementary Fig. 5a,b). Similarly, adipocytes cultured 
from aNotch1 IngWAT expressed higher levels of Ucp1, Ppargc1a, and Prdm16 than the 
WT adipocytes (Supplementary Fig. 5c,d). Moreover, aNotch1 inguinal adipocytes exhibited 
higher O2 consumption rate (OCR) than WT adipocytes upon stimulation with palmitate 
(Supplementary Fig. 5e). These results demonstrate that inhibition of Notch signaling cell-
autonomously enhances the expression of brown (beige) adipocyte-specific genes and 
cellular respiration of white adipocytes.
We also performed Notch gain-of-function studies using SVF cells isolated from the 
subcutaneous WAT of RosaN1ICD mouse, which overexpresses (OE) the constitutive active 
N1ICD upon Cre induction (Fig. 5c). Accordingly, Prdm16 and Ppargc1a were inhibited by 
the N1ICDOE (Fig. 5c). As N1ICDOE upregulates Hes1 and Hey1, we next investigated if 
OE of these genes are sufficient to mimic the observed effect of N1ICDOE. Indeed, either 
Hes1OE or Hey1OE repressed the expression of Prdm16 and Ppargc1a (Fig. 5d,e).
These results prompted us to ask whether the transcriptional repressor Hes1 can directly 
bind the promoter of Prdm16 and Ppargc1a. Bioinformatics analysis identified consensus 
N-Box (CACNAG) sites in the proximal promoter regions of mouse and human Prdm16 and 
Ppargc1a genes (Fig. 5f). Chromatin immunoprecipitation (ChIP) using a Hes1 antibody 
followed by qPCR assay using primers flanking the N-Box region showed that these 
predicted binding sites in Prdm16 and Ppargc1a promoter regions were enriched by 3- and 
13-fold, respectively (Fig. 5g). However, enrichment of these regions was abolished in 
aNotch1 adipocytes (Fig. 5g). As a control, the Hes1 antibody failed to enrich random 
promoter regions that do not contain the N-Box sequence (Fig. 5g), confirming the 
specificity of Hes1 binding to N-Box. Furthermore, Hes1 inhibited Ppargc1a promoter-
driven luciferase reporter activity (Fig. 5h). These results suggest that the canonical Notch 
target Hes1 can directly bind to the promoters of Prdm16 and Ppargc1a to repress their 
expression, therefore inhibiting brown (beige) gene programs.
Notch inhibition induces browning and ameliorates obesity in Lepob mice
To explore the therapeutic potential of targeting Notch signaling to improve glucose 
metabolism, we treated WT mice with a pharmacological inhibitor of the Notch signaling. 
We injected littermate mice of similar body weight with dibenzazepine (DBZ), a γ-secretase 
inhibitor, or vehicle control for 5 days consecutively. Notably, DBZ-treated mice had better 
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glucose tolerance and insulin sensitivity than the control mice (Supplementary Fig. 6a,b). At 
the molecular level, DBZ treatment resulted in higher Ucp1 mRNA and protein expression 
in IngWAT and EpiWAT (Supplementary Fig. 6c,d). Adipocyte volume and number are 
positively correlated with leptin production38, and we found that Lep expression and 
adiposity were reduced, but UCP1+ adipocytes were increased after DBZ treatment 
(Supplementary Fig. 6e,f). Hence, Notch inhibition reduced adiposity and improved glucose 
homeostasis in healthy mice.
To further investigate if Notch inhibition ameliorates obesity under pathological conditions, 
we treated ob/ob mice deficient of Lep (Lepob) with DBZ. Mice were randomly grouped and 
showed no difference in body weight gain prior to treatment (Fig. 6a). Notably, DBZ 
treatment attenuated the body weight gain seen in the vehicle-treated control group, without 
affecting energy intake (Fig. 6a,b). The body weight differences were associated with 
reduced size and weight of various WAT depots in the DBZ-treated mice (Fig. 6c–e and 
Supplementary Fig. 7a,b). DBZ treatment also reduced liver weight and hepatic lipid 
accumulation (Fig. 6d and Supplementary Fig. 7a), consistent with previous observations 
that Notch promotes lipogenesis in hepatocytes and liver steatosis39. In addition, glucose 
tolerance and insulin sensitivity were improved by DBZ treatment (Fig. 6f). Consistent with 
reduced adiposity, DBZ treated mice showed a lower respiration exchange ratio compared 
with control mice (Fig. 6g), indicating that DBZ initiated a metabolic shift towards 
utilization of fat as the energy source. At the molecular level, DBZ inhibited the expression 
of Notch targets Hes1, Hey1 and Heyl as well as Lep (Fig. 6h), but upregulated Ucp1 and 
Ppargc1a expression (Fig. 6h). DBZ also suppressed expression of inflammatory cytokines 
Cd68, Il6 and Il1b (Fig. 6i) that are associated with obesity in humans40. At end of the 
experiment, fed blood glucose concentrations remained low in the absence of DBZ injection 
(Fig. 6j), suggesting a long-term beneficial effect of adipose browning on glucose 
metabolism. These results altogether provide strong evidence that Notch signaling pathway 
can be pharmacologically targeted to prevent and treat obesity, and to improve glucose 
tolerance and insulin sensitivity.
DISCUSSION
Our study reveals a previously unrecognized yet critical role of Notch signaling in regulating 
the browning of adipose tissues and body insulin sensitivity. We have provided compelling 
genetic, physiological, metabolic, histological, cellular and molecular evidence to 
demonstrate that blockage of Notch signaling promotes browning of WAT. Conversely, 
activation of Notch signaling represses expression of genes critical for BAT biogenesis, and 
is associated with whitening of BAT and poor insulin sensitivity. As Notch signaling is 
highly conserved in the animal kingdom, we anticipate that our results in mice will be 
applicable to humans, though future studies dissecting the role of Notch signaling in human 
adipose tissues are imperative.
We used the aP2-Cre mice to drive deletion of Notch1 or Rbpj in adipose tissues. Although 
the aP2-Cre expression domain falls predominantly in immature and mature adipocytes, 
leaky expression of this promoter was reported in several other cell types41-44. Coincidently, 
Notch inhibition has been shown to improve insulin sensitivity through regulating liver lipid 
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metabolism and attenuating atherosclerosis45,46. Even though we used a more adipocyte-
restricted Adipoq-Cre mouse model47 to show that Notch activation conversely induces 
whitening of BAT and reduces glucose tolerance, we cannot exclude the possibility that 
Notch signaling in other cell types may have also contributed the metabolic improvements 
of the aNotch1 mice.
White to brown fat transition involves a series of cellular processes, including increased 
Ucp1 expression and mitochondria production, lipolysis, and β-oxidation. These features are 
all observed in the WAT but not BAT of Notch mutant mice. The differential responses of 
BAT and WAT to Notch signaling are perhaps due to the different embryonic origin of these 
tissues as well as cell type specific gene regulatory programs. Of note, the higher UCP1 
level in aNotch1 white adipocytes is associated with enhanced uncoupled respiration and 
thermogenesis, which may have led to a higher core body temperature. However, as 
mammalian body temperature is controlled by the central nervous system (CNS), the subtle 
increases in core body temperatures in the Notch mutants suggest that Notch signaling may 
also play a role in CNS-mediated body temperature regulation. Alternatively, as both Notch 
signaling and core body temperature exhibit circadian rhythms (i. e. oscillate during a 
day)48,49, perturbations in Notch signaling may have altered the normal rhythm of core body 
temperature.
We used ChIP assay to demonstrate that the transcriptional co-repressor Hes1 directly binds 
to the promoter regions of Ppargc1a and Prdm16, whose expression are inhibited by Hes1 
overexpression. Hey proteins can also inhibit expression of Hes1 targets through 
dimerization with Hes150. Consistent with this notion, we observed that overexpression of 
Hey1 also inhibits the transcription of Ppargc1a and Prdm16. In addition, NICD may recruit 
GCN5, a cofactor of Rbpj transcription complex51 and a major acetyltransferase of PGC1-α 
to repress its transcriptional activity52. Contradictory to our finding, Hes1 has been shown to 
positively regulate expression of Prdm16 during mouse neurogenesis53. As Hes1 is a 
canonical transcriptional repressor, it probably acts through other mediators to upregulate 
Prdm16 indirectly in the neural system. These observations underscore the significance of 
cell context-dependent action of Notch signaling54.
We found that HFD increased Notch activity in WAT, and aNotch1 mutants are resistant to 
HFD-induced obesity. These results indicate that activation of Notch signaling is linked to 
the initiation and development of obesity. Our observation is in agreement with a recent 
study showing that high-fat, high-cholesterol diet increased the expression of Dll4 (a Notch 
ligand) in atheroma and fat tissue in LDLR–deficient mice46. Currently it is unclear how 
Notch signaling is activated at onset of obesity. In addition, a recent study shows that 
excessive leptin production in diet-induced obesity mice activates Notch signaling in 
metastatic breast cancer cells55. As we observed that inhibition of Notch reduced expression 
of Lep in adipose tissues, it is possible that a positive feedback loop between Notch 
signaling and excessive leptin production together accelerates the development of obesity. 
Treating Lepob mice with γ-secretase inhibitor reduced body weight and ameliorated glucose 
metabolism, such drastic effect may be elicited not only by browning of white adipocyte, but 
also through targeting other important metabolic organs, including liver, intestine, which 
directly regulates lipid metabolism and nutrient absorption respectively39,56. 
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Pharmacological approaches specifically targeting the adipose tissue will clarify the direct 
contribution of adipose tissue to metabolic improvements after Notch inhibition.
One important future question is whether Notch signaling is involved in the commitment 
and specification of progenitors to become beige versus classical white adipocytes. Several 
lines of evidence suggest that browning is an inherent capability restricted to certain cell 
population that has a standby or predisposed machinery to respond to browning cues19,57. 
As Notch signaling is widely employed to control cell fate during development, it is 
important to examine how Notch regulates the cell fate specification of embryonic beige 
progenitors.
ONLINE METHODS
Animals
All procedures involving mice were performed in accordance with Purdue University’s 
Animal Care and Use Committee. The Rbpjflox/flox mouse was previously described58 and 
kindly provided by Tasuku Honjo (Kyoto University). Other mice used were purchased from 
Jackson lab: Notch1flox/flox (Stock# 007181)59, aP2-Cre (Stock# 005069)60, Adiponectin–
Cre (Stock# 010803)47, Lepob (Stock# 000632)61. RosaN1ICD (Stock# 008159)62, RosaEYFP 
(Stock# 007920). Mice were in C57BL/6J or mixed background and housed in the animal 
facility with free access to water and standard rodent chow food or high fat diet (TD.06414 
Harlan). Energy intake assay was calculated by measuring food consumption and data was 
presented as the food weight multiple its energy content, then normalized to body weight of 
mice and # of days.
Indirect calorimetry study
Oxygen consumption (VO2), carbon dioxide production (VCO2), respiratory exchange ratio 
(VCO2/VO2) and heat production were measured using an indirect calorimetry system 
(Oxymax, Columbus Instruments) installed under a constant environmental temperature (22 
°C) and 12:12 light cycle. Food and water were free access to mouse in each chamber.
Rectal temperature measurement
A digital thermometer (ETI model: MicroTherma 2) was used in combination with a copper 
thermocouple probe (Type T). The probe was inserted 2 centimeters and 1.6 centimeters into 
anal duct of male and female adult mice (2–4 month-old), respectively. Temperature was 
measured at around 4 pm.
Glucose uptake in WAT explants
Mice were fasted for 20 hours (from 6 pm to 2 pm of next day). Intact inguinal adipose 
tissue was carefully dissected free of visible connective tissue, and placed immediately in 
ice-cold PBS for 5 minutes. WAT explants were then transferred to 37 °C prewarmed 
DMEM (glucose free), supplemented with 10 nM insulin for 30 minutes at 37 °C with 5% 
CO2. For glucose consumption measurement, WAT was then transferred to 24 wells with 1 
ml DMEM supplemented with 100 nM insulin and 1,000 mg L−1 glucose per well, and 
incubated at 37 °C with 5% CO2. Media (50 μl) were collected for glucose measurement at 
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60 and 120 minutes. Glucose consumption was calculated based on the glucose 
concentration of media collected and measured with glucose test strip (Accu-Check Active, 
Roche) read by a glucometer (Accu-Check Active, Roche).The readings were calibrated 
based on a standard curve plotted using a gradient of known concentrations of glucose in 
DMEM (R2 > 0.99).
DBZ treatment
DBZ was purchased from TOCRIS Bioscience (Cat. No. 4489) and used following previous 
studies45,63. DBZ was dissolved in DMSO at 100 mM concentration. Upon use the stock 
was suspended at 1:100 dilution in a solution containing 0.5% Methocel E4M (w/v, Dow 
Chemical) and 0.1% Tween-80 (w/v Sigma) in H2O. This working solution was mixed by 
vortex and sonication for 1 minute each, and IP injected at a dosage of 10 μmol DBZ per kg 
body weight. Control groups were injected with equal volumes of DMSO diluted in E4M/
Tween-80 solution. Control and DBZ treatment groups were randomly grouped. To test the 
effect of DBZ on genetic induced obesity, ob/ob (Lepob) mice (6-week-old, male) were 
treated every other day for one month.
Blood glucose measurement
Five μl blood collected from tail vein was dropped onto glucose test strip (Accu-Check 
Active, Roche) and measured by a glucometer (Accu-Check Active, Roche). For glucose 
tolerance tests, mice were given intraperitoneal (IP) injection of 100 mg ml−1 D-glucose (2 g 
kg−1 body weight for standard diet fed, 1 g kg−1 for high fat diet fed and 0.5 g kg−1 for 
Lepob mice) after overnight fasting, and tail blood glucose concentrations were monitored. 
For insulin tolerance test, mice were fasted for 4 hours before IP administration of human 
insulin (Santa Cruz) (0.75 U kg−1 body weight) and tail blood glucose concentrations were 
monitored. For both GTT and ITT, mouse was singly caged with blinded cage number and 
random orders.
FACS and immunostaining
SVF cells were isolated from inguinal WAT of 2-month old wild-type mice that under chow 
diet. To examine subpopulations of macrophage cells in the SVF, cells were sorted based on 
CD11b and F4/80 staining of SVF cells. For immunostaining, the digested SVF cells were 
cultured overnight and attached cells were stained for CD68 (ab955).
Primary adipocyte culture, transfection and chemical treatment
Stromal-vascular fraction (SVF) cells were isolated from subcutaneous white adipose tissue 
unless otherwise stated. Adipose tissue was minced and digested with 1.5 mg mL−1 
collagenase at 37 °C for 1.5 ~ 2 hours. The digestions were stopped with DMEM containing 
10% FBS, filtered through 100 μm filters and centrifuged at 450 × g for 5 minutes. SVF 
cells were seeded and cultured in growth medium containing DMEM, 20% FBS, 1% 
penicillin/streptomycin at 37 °C with 5 % CO2 for 3 days. Upon confluence, the cells were 
collected and electroporated using a Neon transfection system (Invitrogen). Briefly, 105 cells 
were suspended in 10ulelectroporation buffer, including 2.5 μg plasmids and electroporated 
(1,100 V, 10 ms, 3 times) using a 10 μl tip. After electroporation, the cells were seeded and 
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cultured in 6–well plates. All plasmids used were cloned as described64. Preadipocytes were 
induced to differentiate with induction medium contains DMEM, 10% FBS, 2.85 μM 
insulin, 0.3 μM dexamethasone (DEXA) (Sigma) and 0.63 mM 3-isobutyl-methylxanthine 
(IBMX) (Cayman Chemical) for 4 days, then 4 days in differentiation medium contains 
DMEM, 200 nM insulin and 10 nM T3 until adipocytes mature. During the induction and 
differentiation, cell was treated with 10 μM DAPT (N-[N-(3,5-difluorophenacetyl)-1-
alanyl]-S-phenylglycine t-butyl ester) (Cayman Chemical).
Adipocyte oxygen consumption rate (OCR) measurement
Primary SVF cells from inguinal WAT were isolated and cultured for 3 days before plated in 
XF cell culture microplates (Seahorse Bioscience). SVF cells (10,000 cells) were seeded in 
each well and each sample has 8 replicates. After 6 days of differentiation, cultured 
adipocytes were washed twice and pre-incubated in XF medium for 1–2 h at room 
temperature. The oxygen consumption rate was measured by the XF extracellular flux 
analyzer (Seahorse Biosciences). The chemicals (final concentration, 0.2 mM Palmitate: 34 
μM BSA, 2 μM Rotenone) were preloaded into cartridges and injected into XF wells in 
succession. OCR was calculated as a function of time (picomoles per minute).
Total RNA extraction, cDNA synthesis and real-time PCR
Total RNA was extracted from cells or tissues using Trizol Reagent according to the 
manufacturer’s instructions. RNA was treated with RNase-free DNase l to remove 
contaminating genomic DNA. The purity and concentration of total RNA were determined 
by a spectrophotometer (Nanodrop 2000c, Thermo Fisher) at 260 nm and 280 nm. Ratios of 
absorption (260/280 nm) of all samples were between 1.8 and 2.0. Then 5 μg of total RNA 
were reverse transcribed using random primers with M-MLV reverse transcriptase 
(Invitrogen). Real-time PCR was carried out in a Roche Light Cycler 480 PCR System with 
SYBR Green Master Mix (Roche) and gene-specific primers as previously described64,65. 
The 2−ΔΔCt method was used to analyze the relative changes in each gene’s expression 
normalized against 18S rRNA expression.
Protein extraction and western blot analysis
Protein was isolated from cells or tissue using RIPA buffer contains 50 mM Tris-HCl (pH 
8.0), 150 mM NaCl, 1% NP-40, 0.5% sodium deoxycholate and 0.1% SDS. Protein 
concentrations were determined using Pierce BCA Protein Assay Reagent (Pierce 
Biotechnology). Proteins were separated by sodium dodecyl sulfate polyacrylamide gel 
electrophoresis (SDS-PAGE), transferred to a polyvinylidene fluoride (PVDF) membrane 
(Millipore Corporation), blocking in 5% fat-free milk for 1 hour at room temperature, then 
incubated with primary antibodies in 5% milk overnight at 4 °C. The UCP1 (ab23841), 
N1ICD (ab8925) and Hes1 (ab71559) antibodies were from Abcam, and PGC1-α 
(sc-13067), GAPDH (sc-32233) and Actin (sc-130656) were from Santa Cruz 
Biotechnology. The horseradish peroxidase (HRP) conjugated secondary antibody (anti-
rabbit IgG or anti-mouse IgG, Santa Cruz Biotechnology) was diluted at 1:5,000. 
Immunodetection was performed using enhanced chemiluminescence western blotting 
substrate (Pierce Biotechnology) and detected with a Gel Logic 2200 imaging system 
(Carestream). Alternatively, membrane was incubated with infrared secondary antibody 
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(Alexa Fluor 790 goat anti-mouse IgG, A11357, Alexa Fluor 680 goat anti-rabbit IgG, 
A21109, life technologies, USA) and the signals were detected by using the Odyssey 
infrared image scanning system. Results shown in figures are representative result from at 
least three independent experiments.
Hematoxylin-eosin (H&E) and immunohistochemistry (IHC) staining
Adipose tissues were fixed in 10% formalin for 24 hours at room temperature. Then the 
tissues were embedded into paraffin and cut at 4 μm thick, de-paraffinized, and rehydrated 
through xylene, ethanol, and water by standard methods. For antigen retrieval, slides were 
submerged in 0.01 M sodium citrate (pH 6.0) and heated to 96 °C for 20 minutes in a 
laboratory microwave (PELCO). Immunohistochemistry was performed on a Dako 
Autostainer (Dako, Carpinteria, CA). Slides were incubated with 3% hydrogen peroxide and 
2.5% normal horse serum (S-2012, Vector), followed by incubation with rabbit polyclonal 
anti-UCP1 primary antibody diluted 1:200 in 2.5% normal horse serum (Vector, S-2012) for 
60 minutes. Signal was detected with an anti-rabbit IgG Polymer Detection Kit (MP-7401, 
Vector) Labeling and was visualized with 3, 3′-diaminobenzidine (DAB) as the chromogen 
(SK-4105, Vector). Slides were counterstained with Harris hematoxylin (EK Industries, 
Joliet, IL) and whole slide digital images were collected at 20X magnification with an 
Aperio Scan Scope slide scanner (Aperio, Vista, CA). Images shown were representative 
result of at least three biological replicates. Scanned images of H&E staining were analyzed 
by Photoshop CS3 to calculate cell numbers. Averaged adipocyte size was calculated as the 
image area divided by cell numbers.
Chromatin immunoprecipitation (ChIP) and genomic DNA recombination assay
Cultured inguinal adipocyte of both wild-type and mutant mice was cross-linked with 1% 
formaldehyde in DMEM medium for 10 minutes at room temperature followed by the 
addition of 125 mM glycine for 5 min at room temperature, after which cells were washed 1 
time with ice-cold PBS and scraped into SDS lysis buffer. The cells were further sonicated 
and diluted for immunoprecipitation with the indicated antibodies. The immunoprecipitates 
were eluted and reverse cross-linked overnight at 65 °C. DNA fragments were purified using 
the Cycle Pure kit (Omega Bio-Tek), and qPCR was performed with primers listed in 
Supplementary Table 1. Genomic DNA was extracted from adipose tissue and amplified 
with primers listed in supplementary Table 1.
Luciferase assay
HEK293A cells were seeded into 12–well plate 1 day before lipofectamine 2000 mediated 
transfection. PGC1-α promoter luciferase plasmid was purchased from Addgene, generated 
by Handschin C, et al66. For transfection of each well, 100 ng Renilla plasmid, 400 ng 
pGL3-Basic (or pGL3-PGC1-α) and 600 ng Hes1 plasmid (or its blank control plasmid) 
were cotransfected following manufacture’s instruction. Cells were harvested 36 hours after 
transfection and analyzed with Dual-Luciferase Reporter Assay System (Promega).
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Statistical analyses
Trial experiments or experiments done previously were used to determine sample size with 
adequate statistical power. Measurement values that are beyond fence as determined by 
interquartile range were considered as outlier and excluded from following statistical 
analysis. All analyses were conducted with student t test with two-tail distribution. 
Comparison with a P value < 0.05 was considered significant.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. 
Browning phenotype of WAT in Notch mutant mice. (a) Representative images of anterior-
subcutaneous WAT (arrows) and IngWAT (asterisks), lower panel shows IngWAT. (b) 
Ratio of adipose tissue weight to body weight, n = 7 except for epiWAT (n = 9). (c) 
Representative images of Hematoxylin & Eosin (H&E) and UCP1 staining of IngWAT 
(left), scale bar, 50 μm, and average inguinal adipocyte size (right). (d–f) Relative 
expression of genes in WT and aNotch1 IngWAT, (f middle, n = 6), (f right, n = 8). (g) 
Representative images of IngWAT from WT and aRbpj mice. (h) Gene expression in 
IngWAT. (i,j) Rectal temperature measurement, (j, n = 7). *P < 0.05, **P < 0.01, ***P < 
0.001. Data are means ± SEM. n = 4 pairs of mice unless otherwise indicated.
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Figure 2. 
Improved glucose metabolism in Notch mutant mice. (a,b) Blood glucose concentrations 
during IP-GTT (a) and IP-ITT (b) performed on 2–4 month-old WT and aNotch1 mice, n = 
6. (c) Insulin stimulated glucose uptake of IngWAT explant from fasted 2–4 month-old WT 
(n = 4) and aNotch1 mice (n = 3). (d,e), IP-GTT (d, n = 4) and IP-ITT (e, n = 10) on 2–4 
month-old WT and aRbpj mice. (f–h) Average day and night O2 consumption, CO2 
production, and heat production, n = 6. (i) Representative histological analysis result of 
IngWAT from aNotch1 and WT mice treated at 4 °C for 1 week, scale bar, 1 mm (middle), 
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50 μm (right). (j) Western blot result of sample as in panel i. *P < 0.05, **P < 0.01, ***P < 
0.001. Data are means ± SEM.
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Figure 3. 
aNotch1 mice were resistant to HFD-induced obesity. (a,b) Growth curve (a) and energy 
intake assay (b, n = 4) of WT and aNotch1 fed with HFD. (c) Blood glucose concentrations 
during IP-GTT after glucose injection into fasted mice. (d) Blood glucose concentrations 
during IP-ITT after injecting insulin into fasted mice. (e) Gene expression assay of Notch 
receptors, Notch targets and Lep in WAT from 3 weeks’ standard diet (SD) and HFD fed 
mice, n = 8. (f) Representative result of western blot for Notch activity of sample as in e. *P 
< 0.05, **P < 0.01, ***P < 0.001. Data are means ± SEM. n = 5 pairs of mice unless 
otherwise indicated.
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Figure 4. 
Activation of Notch1 in adipocytes inhibits browning and glucose metabolism. (a) Relative 
expression of N1ICD and its target genes in WAT. (b,c) Blood glucose concentrations 
during IP-GTT (b, n = 6) and IP-ITT (c) performed on 5–8 week-old WT and Adipoq/
N1ICD mice. (d–f) O2 consumption (d), CO2 production (e), and heat production (f). (g) 
Rectal temperature, n = 5. (h) Relative expression of BAT and mitochondria marker genes 
in IngWAT (top) and BAT (bottom). (i) Western blot of IngWAT. (j) H&E staining of BAT 
section, scale bar, 50 μm. *P < 0.05, **P < 0.01, ***P < 0.001. Data are means ± SEM. n = 
4 pairs of mice unless otherwise indicated.
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Figure 5. 
Notch signaling inhibits expression of Ppargc1a and Prdm16 genes in cultured white 
adipocyte. (a) Gene expression of Notch1 and Hes1 (left), Prdm16 and Ppargc1a (right) in 
Notch1flox/flox preadipocytes after transfection with Cre or GFP plasmids (control). (b) Gene 
expression of Notch target (left), BAT-related genes (middle) and protein level of N1ICD, 
UCP1, PGC1-α (right) in cultured WT white adipocytes treated with DAPT during 
induction and differentiation, n = 6. (c) Gene expression in RosaN1ICD preadipocytes after 
transfection with Cre or GFP (control) plasmids. (d,e) Gene expression of WT preadipocytes 
after transfection with Hey1 (d) or Hes1 (e) plasmids. (f) Conserved N box domains on 
Prdm16 (top) and Ppargc1a (bottom) promoters of both human and mouse. (g) Chromatin 
immunoprecipitation (ChIP) using Hes1 antibody followed by qPCR assay, n = 4. (h) 
Luciferase assay of HEK293 cells after cotransfection of pGL3-PGC1-α (or pGL3-Basic) 
plasmids with Renilla plasmids and Hes1 (or its control, ctrl) plasmids, n = 5. *P < 0.05 and 
**P < 0.01. Data are means ± SEM. n = 3 unless otherwise indicated.
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Figure 6. 
Inhibition of Notch in Lep deficient obese mice (Lepob) ameliorates obesity and glucose 
metabolism. (a) Body weight ratio normalized to day 0, arrows mark doses of DMSO or 
DBZ injection. (b) Energy intake assay. (c) WAT images, anterior subcutaneous WAT (as-
WAT). (d) Tissue weight. (e) H&E staining result of IngWAT, and adipocyte size. (f) 
Plasma glucose measurement during IP-GTT (left), or during IP-ITT (right). (g) Respiration 
exchange ratio of mice after treated with DMSO or DBZ for 22 days. (h,i), Relative 
expression of Notch targets (h left), adipocyte genes (h middle), UCP1 protein (h right), and 
inflammation-related genes (i) in IngWAT. (j) Fed-plasma glucose concentrations at dates 
shown, arrows indicate DMSO or DBZ injection (started from day 0 as shown in panel a). 
*P < 0.05, **P < 0.01, ***P < 0.001. Data are means ± SEM, n = 5.
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